RISANKIZUMAB vs RISPERIDONE: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
RISANKIZUMAB vs RISPERIDONE: Safety Overview
| Metric | RISANKIZUMAB | RISPERIDONE |
|---|---|---|
| Total FAERS Reports | 2,642 | 79,288 |
| Deaths Reported | 41 | 4,120 |
| Death Rate | 1.6% | 5.2% |
| Hospitalizations | 439 | 18,771 |
| Average Patient Age | 52.1 yrs | 31.9 yrs |
| % Female Patients | 51.3% | 15.6% |
| FDA Approval Date | N/A | Apr 12, 2007 |
| Manufacturer | AbbVie Inc. | NuCare Pharmaceuticals, Inc. |
| Route | SUBCUTANEOUS | ORAL |
| Marketing Status | N/A | Prescription |